VEGFA and gastric cancer: Among them, the application of anti-angiogenic drugs in the comprehensive treatment of gastric cancer has made great progress, including monoclonal antibodies targeting VEGF, tyrosine kinase receptor inhibitors, and antibodies targeting VEGFR.